PACS1 Protein is a protein encoded by the PACS1 gene. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.
[^2]
Gene Name
[^3]
[PACS1](/genes/pacs1)
UniProt ID
[Q6UVK0](https://www.uniprot.org/uniprot/Q6UVK0)
PDB Structures
Not determined
Molecular Weight
130.5 kDa
Subcellular Localization
Golgi apparatus, endosomes, ER
Protein Family
PACS family, membrane traffic proteins
PACS-1 (Phosphofurin Homology and Claudin Homology domain-containing protein 1) is a 1,208-amino acid protein with several functional domains:
- Furin-like domain: Central region involved in protein processing
- Central claudin homology domain: Mediates homooligomerization
- Multiple phosphorylation sites: Regulate protein function and localization
- N-terminal regulatory region: Contains sorting motifs
The protein serves as a cargo adaptor for membrane protein trafficking between the trans-Golgi network, endosomes, and the plasma membrane 1.
In neurons, PACS1 regulates:
- Synaptic vesicle trafficking: Controls neurotransmitter release through sorting of synaptic proteins
- Receptor endocytosis: Manages trafficking of neurotransmitter receptors (AMPA, NMDA, GABA)
- Protein sorting: Directs membrane proteins to their proper cellular compartments
- Dendritic spine morphology: Influences synaptic structure and plasticity
- Axonal cargo transport: Participates in axonal trafficking pathways
PACS1 is widely expressed in neurons and is essential for maintaining synaptic function 2.
- PACS1-mediated trafficking is disrupted in AD neurons
- Altered sorting of amyloid precursor protein (APP) and BACE1
- Contributes to Aβ production through mislocalization of processing enzymes
- Synaptic vesicle trafficking deficits link to cognitive decline 3
- Regulates trafficking of dopamine receptors
- Involved in endosomal sorting of alpha-synuclein
- May affect Lewy body formation through protein sorting defects
- DJ-1 and PACS1 interactions in PD pathogenesis
- PACS1 mutations cause syndromic intellectual disability (Schuurs-Hoeijmakers syndrome)
- Characterized by developmental delay, dysmorphic features, and autism
- Heterozygous missense mutations are the primary cause
- Altered PACS1 expression in epileptic brain tissue
- Contributes to synaptic dysfunction in seizure disorders
- No direct PACS1-targeted drugs are currently available
- Viral-mediated gene therapy: Under investigation for PACS1-related disorders
- Modulators of membrane trafficking: Indirect therapeutic approach
- PACS-1 as a sorting adaptor for membrane protein trafficking (2001)
- PACS1 in aging and neurodegenerative disease (2019)
- PACS1 mutations and intellectual disability syndrome (2019)
- Membrane trafficking in Alzheimer's disease (2020)